a month ago
ALNY
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 5%
#240 out of 4861 analysts
Average Return
+13.35%
Win Rate
59%65 out of 111
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Insmed IncINSM | +199.43% | $24.62 | $73.72 | 2023-11-20 - 2024-11-19 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-26 - 2020-06-10 | Strong Buy |
Ascendis Pharma AASND | +134.77% | $27.90 | $65.50 | 2017-05-11 - 2018-05-11 | Strong Buy |
Intra Cellular Therapies IncITCI | +93.36% | $68.20 | $131.87 | 2024-06-12 - 2025-04-01 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
a month ago
ASND
2 months ago
INSM
3 months ago
ASND
5 months ago
INSM
6 months ago
ITCI
6 months ago
ONC
8 months ago
BMRN
8 months ago
ASND
8 months ago
ONC
8 months ago
JAZZ
9 months ago
DNLI
10 months ago
INSM
10 months ago
MIRM
a year ago
INSM
2 years ago
ITCI
2 years ago
LEGN
2 years ago
LEGN
2 years ago
VRTX
2 years ago
MRNA
3 years ago
IMCR
3 years ago
UTHR
3 years ago
TVRD
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunocore Holdings PLCIMCR | 5 | Strong Buy | $50.00 | +75.99% | Maintains | 7 days ago |
Novocure LtdNVCR | 4 | Hold | $28.00 | +79.72% | Maintains | 11 days ago |
Ionis Pharmaceuticals IncIONS | 4 | Hold | $45.00 | +58.45% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 5 | Strong Buy | $328.00 | +39.84% | Upgrades | a month ago |
Moderna IncMRNA | 12 | Strong Sell | $33.00 | +33.52% | Maintains | a month ago |
Ascendis Pharma AASND | 9 | Strong Buy | $200.00 | +21.18% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Strong Buy | $209.00 | +103.35% | Maintains | 2 months ago |
Insmed IncINSM | 7 | Strong Buy | $92.00 | +26.63% | Maintains | 2 months ago |
Denali Therapeutics IncDNLI | 5 | Strong Buy | $24.00 | +88.38% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 7 | Strong Buy | $500.00 | +2.23% | Maintains | 4 months ago |
Biontech SeBNTX | 10 | Hold | $122.00 | +23.53% | Maintains | 5 months ago |
Intra Cellular Therapies IncITCI | 6 | Strong Buy | $89.00 | -32.51% | Maintains | 6 months ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $109.00 | +84.21% | Maintains | 6 months ago |
Incyte CorpINCY | 5 | Hold | $71.00 | +21.97% | Maintains | 6 months ago |
Alkermes PLCALKS | 6 | Hold | $26.00 | -3.70% | Maintains | 6 months ago |
Beigene LtdONC | 4 | Strong Buy | $235.00 | +1.74% | Maintains | 6 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $30.00 | +293.70% | Initiates Coverage On | 6 months ago |
Halozyme Therapeutics IncHALO | 5 | Hold | $57.00 | -3.04% | Downgrades | 7 months ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $54.00 | +77.51% | Maintains | 9 months ago |
Mirum Pharmaceuticals IncMIRM | 3 | Strong Buy | $39.00 | -0.26% | Maintains | 10 months ago |
United Therapeutics CorpUTHR | 6 | Strong Buy | $300.00 | +5.36% | Maintains | a year ago |
Stoke Therapeutics IncSTOK | 2 | Hold | $13.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | N/A | Downgrades | a year ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Strong Buy | $10.00 | N/A | Reinstates | a year ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $76.00 | N/A | Maintains | 2 years ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | N/A | Downgrades | 2 years ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Amarin Corp PLCAMRN | 4 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $240.00 | N/A | Upgrades | 3 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 4 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 5 years ago |
Axcella Health IncAXLA | 2 | Strong Buy | $275.00 | N/A | Maintains | 5 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 5 years ago |
Mersana Therapeutics IncMRSN | 4 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 6 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 6 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Advanced Accelerator Applications SaAAAP | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.